Clinical Development in the Precision Medicine Era

Precision medicine is transforming oncology trials by targeting genetic profiles. Discover how sponsors can adapt trial designs and strategies to stay ahead.

Accelerating Oncology - Inside the EPON Network

Unlocking CNS insights: Continuous CSF sampling in first-in-human Alzheimer’s trials

Epigenetic MoA drug development: Navigating regulatory barriers to enable an hAME study in healthy volunteers

Radiogenomics: Revolutionizing clinical trials and precision medicine

Radiogenomics is transforming oncology trials by linking imaging, genomics, and AI. See how Fortrea helps sponsors operationalize this approach.

Seeing the future: How Fortrea is shaping the next chapter in ophthalmology trials

Clinical trial execution: Reimagine each step to drive productivity gains